The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results.

ABSTRACT:

Objectives

This study sought to assess the effect of the addition of coronary artery bypass grafting (CABG) to medical therapy on mode of death in heart failure.

Background

Although CABG therapy is widely used in ischemic cardiomyopathy patients, there are no prospective clinical trial data on mode of death.

Methods

The STICH (Surgical Treatment for Ischemic Heart Failure ) trial compared the strategy of CABG plus medical therapy to medical therapy alone in 1,212 ischemic cardiomyopathy patients with reduced ejection fraction. A clinical events committee adjudicated deaths using pre-specified definitions for mode of death.

Results

In the STICH trial, there were 462 deaths over a median follow-up of 56 months. The addition of CABG therapy tended to reduce cardio

SUBMITTER: Carson P 

PROVIDER: S-EPMC3829618 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature